Jiangsu Hengrui
Tracked across 1 events · 6 articles · First seen Apr 22, 2026 · Last active Jun 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Jiangsu Hengrui reported strong Q1 2026 results with significant revenue and net profit growth, driven by innovative drugs and successful business development, including the Nasdaq-100 listing of Kailera Therapeutics.
Apr 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Jiangsu Hengrui live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard